We have placed cookies on your computer to help make this website better. We use a PIWIK Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by PIWIK (e.g. deny use/opt-out). More info.

Confirm

Global leaders in pain research

Re-defining pain through patient-inspired R&D

Pain is a huge burden on society, impacting not only patients but their families, friends and colleagues. There has been limited success in discovering new pain treatments. Many conditions have no standard of care and in cases where they do exist, they have limited efficacy. We want to change this.

We want to re-define the field of pain, creating specialised treatments through patient-inspired R&D.
We aim to:
  • Better understand the DISEASE state to identify new TARGETs
  • Develop treatments with both symptomatic and disease-modifying potential
  • Improve our understanding of the link between inflammation and pain
  • Target significant unmet needs within niche disease areas
  • Broaden our research reach through partnerships and collaborations
  • Investigate small molecule approaches.
We will achieve our goals by bringing together patient experience, payors’ needs and innovation networks.

A different approach

We see pain as a disease, not a symptom

We understand pain is not just a symptom but also an entire condition in itself that requires specialised treatment. We know that pain is different for everyone and the experience and symptoms don’t just depend on the type of condition, but also the individual patient. By understanding how and why pain is generated in a variety of conditions; we are driving development into innovative pain solutions that will have a truly meaningful impact on patient lives.

 

Patient perspective

Patients are central in the journey towards developing effective pain solutions. Through our work with patient organisations and direct interaction with patients, we have been able to create tangible improved outcomes for patients.

 

Medical expert perspective

Expert knowledge from medical professionals and researchers is the foundation for our research.

 

Basic science perspective

Through patient and control tissues, we are starting to identify which genes, RNAs, proteins or metabolites are involved in different disease characteristics.